4 Surprising Benefits of the Flu Shot

4 Surprising Benefits of the Flu Shot

The vaccine can protect you from influenza, and it may have some other perks as well

AARP | by Beth Howard | October 3, 2022 | Flu Shot | Health Insurance with Shield Insurance

Not getting sick from the flu is reason enough to roll up your sleeve for a flu vaccine every fall. And along with preventing millions of cases of influenza each year, flu shots also reduce hospitalizations for complications of this misery-making seasonal illness.

A 2021 study from researchers at the Centers for Disease Control and Prevention (CDC) found that adults who got vaccinated were 26 percent less likely to be admitted to the intensive care unit and 31 percent less likely to die from the flu compared to those who were unvaccinated. There seems to be protection from illness even when vaccines aren’t perfectly matched to the strain of flu virus circulating (since the shot is formulated months in advance).

But evidence suggests that there are other payoffs beyond defense from fever, fatigue, chills, and aches.

“People don’t really appreciate the other potential benefits of flu shots,” says Michelle Barron, M.D., senior medical director of infection prevention and control for UCHealth in Aurora, Colorado. “It’s actually arming your immune system to fend off other problems.”

Here are four unexpected ways a flu vaccine can benefit the body and the brain.

1. A boost for the brain?

Previous research has suggested that flu vaccines may protect the brain from dementia, and a new study from the McGovern Medical School at UTHealth in Houston makes the case even stronger.

This study, published in the Journal of Alzheimer’s Disease, compared more than 47,000 people age 65 and older who were vaccinated against flu to a similar group of nearly 80,000 people who were not vaccinated. The findings: Those who got a flu shot were 40 percent less likely to develop Alzheimer’s disease over a four-year period.

“We weren’t actually expecting it to be that high,” says study coauthor Avram S. Bukhbinder, M.D., now a neurologist at Massachusetts General Hospital in Boston.

Bukhbinder has several theories for the vaccination’s potential effects on the brain. Perhaps by preventing the flu, the shot quells inflammation that can lead to harmful brain changes.

His most intriguing hypothesis is that vaccines alter the brain’s overall defenses. “There’s good evidence that when we get these vaccines, they help us make antibodies to the specific pathogen — the influenza virus,” he says. “But they may also modify the immune system in such a way that it’s better at either cleaning up amyloid and tau [the proteins responsible for the plaques and tangles that are the hallmarks of Alzheimer’s] or by preventing these proteins from building up in the first place.” 

2. The flu shot is linked to a stronger heart

A history of heart disease or a stroke can make flu more likely and more dangerous. In addition, flu can be a trigger for heart attacks and strokes in people at high risk for them. 

According to a 2018 Canadian study, people who got the flu were 6 times more likely to have a heart attack within a week of getting the diagnosis. And Columbia University researchers saw a significant jump in strokes in the month after fighting the flu, according to new research published in the American Heart Association’s journal Stroke

A flu shot can also spare you the potential heart harms. A new study led by the University of Toronto that incorporated six previous studies covering more than 9,000 patients showed that people who received a flu vaccine had a 34 percent lower risk of a major cardiovascular event in the 12 months following vaccination. Higher-risk vaccinated individuals with acute coronary syndrome — a group of conditions that abruptly stop blood flow to the heart — had a 45 percent risk reduction of a major cardiovascular event, and a 56 percent reduced risk of dying from heart disease in the year after they got the shot, according to the findings, which appear in JAMA Network Open. How the flu shot protects the heart isn’t fully known, but it may have to do with the plaques that build up on the artery walls of people with heart disease. The body’s immune response to the flu creates inflammation that is believed to disrupt these fat deposits, causing blood clots that may trigger heart attacks and strokes.

“The vaccine may interact with the body’s immune system and inflammatory processes to help stabilize plaques that might be present in blood vessels, thus preventing these plaques from rupturing and causing further problems,” says lead study author Bahar Behrouzi Homa, an M.D./Ph.D. candidate at the university. 

3. The flu shot could curb complications from other chronic conditions

Read the rest of the article here…


Wanna read more great articles featured by Shield Insurance Agency?

Read More

Tracking COVID-related securities litigation

Tracking COVID-related securities litigation: 4 reasons cases may be on the rise

When COVID-19 hit in March 2020, many in the insurance industry anticipated a wave of litigation that would mirror the influx of lawsuits after the 2008 recession. During that year, investors trying to recuperate lost funds filed more than 200 new cases, increasing securities litigation by nearly 20 percent from 2007. So far, however, this prediction has not played out—at least not yet.

Courts have experienced a slowdown in securities-related lawsuits since the beginning of the pandemic, with only 29 cases filed since the initial shutdown. But some experts believe a surge of COVID-19-related litigation is on the horizon. In this article, we’ll explore what we know based on the COVID-19 securities cases that have been filed so far, and why there could be a rise in legal activity and related directors and officers (D&O) claims. 

COVID-19 securities litigation: what we know so far

Unlike other events that precipitate stock market crashes, the pandemic has had a unique impact on the economic and legal landscape—in large part because it’s unlike any other financial crisis we’ve experienced. Despite the uniqueness of the situation, however, it’s possible to identify several reasons why the pandemic hasn’t sparked the same rise in securities litigation that we saw in 2008.

Importantly, this time the government quickly provided aid to help offset the pandemic’s impact on the stock market. On top of that, many companies went above and beyond to share information with stakeholders following the Securities and Exchange Commission’s (SEC) guidance from April 2020 to “disclose as much information as is practicable regarding [your company’s] financial and operating status(…).” These factors, plus the widespread belief that COVID-19 was just a temporary setback, likely kept many investors out of the courtroom.

Even with the litigation slowdown, however, there are a few cases currently working their way through the courts. The following is a breakdown of the three main types of COVID-19-related securities lawsuits experts have observed so far.

  • Outbreak-related cases

A few cases have been filed against companies that experienced outbreaks in their facilities. For example, some cruise-ship companies, prisons, and long-term care facilities are facing securities litigation.

  • Cases against false financial claims 

Companies that claimed to be able to profit from the pandemic are also facing litigation. For example, shareholders at some vaccine development companies recently sued over false claims around the development of a COVID-19 vaccine. 

  • Cases in heavily impacted industries

Finally, shareholders with investments in companies most disrupted by the pandemic have started to file suits. Heavily impacted industries include real estate investment trusts (REITs) and businesses in the entertainment and travel industries.

4 areas of uncertainty around post-pandemic securities litigation

With so few cases in court today, why could there be a rise in COVID-19-related securities litigation and D&O claims? Here, we review four factors that could make an impact.

1. The nature of the stock market

Since March 2020, the stock market has been volatile, and it will likely continue that pattern for months, or even years. Because of this, reductions in stock prices will take time to develop. Many shareholders may wait until the market levels off to litigate to have a clearer picture of the long-term impact 

2. Stricter regulations from the SEC

According to news outlets, the new administration is signaling a tougher regulatory stance than its predecessor. If the SEC tightens restrictions and enforces stricter disclosures for publicly held companies, this may benefit future plaintiffs.

3. A lack of comparable cases and precedent

As noted above, there have only been a few securities lawsuits to date around COVID-19 losses, and most of the cases are still working their way through the court system. Without precedent to use as a guide, only time will tell if cases survive motions to dismiss and the percentage that is in favor of plaintiffs. If more plaintiffs pursue cases and are successful, it could whet the appetite for more suits.

4. Continued economic uncertainty

Click here for the rest of the story…


Check out other blogs by Shield Insurance

Read More